Annual mRNA Day on November 16, 2021
Vložit
- čas přidán 10. 09. 2024
- Click Here to Register:
live.classy.or...
Has there ever been a more exciting year for mRNA than 2021?! The extraordinary success in developing and deploying RNA vaccines has saved countless lives and signals a new era in mRNA biology and medical applications.
On November 16, 2021, TriLink BioTechnologies will proudly host the Annual mRNA Day-a global, virtual event in partnership with Genetic Engineering & Biotechnology News (GEN) and The CRISPR Journal. This free virtual summit will showcase novel and ongoing mRNA vaccine efforts along with a discussion of mRNA applications outside of infectious disease.
TriLink BioTechnologies is making a donation for every registrant to UNICEF USA to support ACT-A efforts to help end the pandemic through treating and vaccinating vulnerable communities across the globe.
We have gathered a superb group of experts from across industry and academia to share their latest groundbreaking efforts in the world of mRNA biology and medicine. The summit kicks off with a keynote address from Dr. Linda Marbán, President, CEO, and Director of Capricor Therapeutics, which is developing innovative cell and exosome-based therapeutics. Additionally, you will hear presentations from Dr. Daniel Anderson at MIT (Nucleic Acid Delivery Systems) and a joint discussion with Drs. Norbert Pardi and Mohamad-Gabriel Alameh (mRNA Vaccine History and Applications for COVID-19 and Influenza). Over this four-hour event, you will hear an array of outstanding speakers in two parallel tracks covering many aspects of mRNA therapeutics, from synthesis to delivery.
In November 2019, San Diego officially proclaimed November 20 “mRNA Day” to honor the grand opening of the TriLink manufacturing facility and Maravai Life Sciences headquarters. We’re excited to carry the torch to establish a tradition of celebrating mRNA research by bringing together leaders in the industry to share their scientific knowledge, research expertise, and predictions for the future.